Christoph Westphal, Longwood Fund general partner
Christoph Westphal bags a $170M Fund V, slated to help breed some new biotechs at Longwood
Christoph Westphal has closed the fifth in a series of funds for Longwood with $170 million to play with. That’s not a blockbuster by any means in this day and age, but it will keep him in the high-profile position he’s enjoyed for years now in biotech.
The Boston-based fund counts itself as one of the biotech breeders in the business, specializing in startups. And Westphal’s involvement in some of the hub’s biggest successes, including the early days at Alnylam, has helped secure his rep in the community.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
